Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sandrine Aspeslagh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
Gomez-Roca, C., Cassier, P., Zamarin, D., Machiels, J-P., Luis Perez Gracia, J., Stephen Hodi, F., Taus, A., Martinez Garcia, M., Boni, V., Eder, J. P., Hafez, N., Sullivan, R., Mcdermott, D., Champiat, S., Aspeslagh, S., Terret, C., Jegg, A-M., Jacob, W., Cannarile, M. A., Ries, C. & 10 others, , May 2022, In: Journal for immunotherapy of cancer. 10, 5, 15 p., e004076.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Assessment of repeatability and uptake quantification of (68)GaNOTA-anti-HER2 sdAb PET/CT in patients with locally advanced or metastatic breast cancer
Gondry, O., Xavier, C., Waelput, W., Al Dabssi, O., Vanhoeij, M., Aspeslagh, S., Joris, S., Fontaine, C., Verfaillie, G., De Greve, J., Glorieus, K., Luyten, I., Vandenbroucke, F., Bourgeois, S., Raes, L., Thyparambil, S., Devoogdt, N., Vaneycken, I., Cousaert, J., Caveliers, V. & 3 others, , 15 Feb 2022, In: Cancer Research. 82, 4Research output: Contribution to journal › Meeting abstract (Journal)
-
COVID-19 and Cushing's disease in a patient with ACTH-secreting pituitary carcinoma
de Filette, J. M. K., Sol, B., Awada, G., Andreescu, C. E., Unuane, D., Aspeslagh, S., Poelaert, J. & Bravenboer, B., 28 Feb 2022, In: Endocrinology, diabetes & metabolism case reports. 2022, 1, 21-0182.Research output: Contribution to journal › Article › peer-review
Open Access -
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
De Jaeghere, E. A., Tuyaerts, S., Van Nuffel, A. M. T., Belmans, A., Bogaerts, K., Baiden-Amissah, R., Lippens, L., Vuylsteke, P., Henry, S., Trinh, X. B., van Dam, P. A., Aspeslagh, S., De Caluwé, A., Naert, E., Lambrechts, D., Hendrix, A., De Wever, O., Van de Vijver, K. K., Amant, F., Vandecasteele, K. & 1 others, , 12 Aug 2022, In: Cancer Immunol Immunother.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacological adaptations to immunosuppressive therapy in cancer patients with autoimmune disease treated with immune checkpoint inhibitors
Wuyts, S., Cappelle, C. A., Verhaert, M. & Aspeslagh, S., 1 Apr 2022.Research output: Unpublished contribution to conference › Poster